One-Day HPV test and treatment could cut cervical cancer in women with HIV

NCT ID NCT07225530

Recruiting now Disease control Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a same-day HPV screening and treatment approach can help prevent cervical cancer in women living with HIV in the Dominican Republic. 600 women will be randomly assigned to either the new same-day method or standard care. The goal is to see if more women complete the full screening-to-treatment process with the faster approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Same-day HPV screening and ablative treatment
What this could lead to: If successful, this approach could make cervical cancer prevention faster and more accessible for women with HIV in low-resource settings.
What could go wrong: This is an implementation study, not a drug trial. Results may not apply to other regions or populations, and the approach may not reduce cancer rates long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease human papilloma virus infection Uterine Cervical Neoplasms cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HIV INFECTIONS HPV INFECTION

Contacts and locations

Locations

Clínica de Familia La Romana
RECRUITING

La Romana, Dominican Republic

More trials for these conditions

Other studies related to the condition(s) this trial covers.